We are delighted to have supported Psych Capital Plc on their Admission to the Aquis Stock Exchange Growth Market.
The Company has raised gross proceeds of £810k from the issue and allotment of 16,200,000 Placing Shares.
Psych Capital Plc will look to identify, fund and support the building of British and European companies across three core pillars: therapeutic treatments, drug development, and data/AI. Its mission is to support a new wave of innovators who are well positioned to challenge the status-quo and revolutionise how society deals with mental health conditions.
PKF acted as reporting accountant on the transaction and the Capital Markets team included Dominic Roberts, Adam Humphreys and Lauren Haslam.